University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Micro vs. Standard Trabeculectomy Study

Not Applicable

Conditions: Glaucoma

Interventions: Procedure: Microtrabeculectomy
Procedure: Standard Trabeculectomy

First Posted Date: 2015-11-06

Last Posted Date: 2018-02-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 240

Registration Number: NCT02598765

Locations: 🇳🇵
Lumbini Eye Institute, Nepal, Siddharthanagar, Nepal

The Role of Orexin in Human Panic Disorder

Phase 4

Completed

Conditions: Panic Disorder

Interventions: Drug: suvorexant
Drug: placebo

First Posted Date: 2015-11-01

Last Posted Date: 2021-07-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 3

Registration Number: NCT02593682

Locations: 🇺🇸
UCSF Fresno Medical Education Program, Fresno, California, United States

The Effect of a Novel Audit and Feedback Bundle on Inpatient Performance

Not Applicable

Completed

Conditions: Quality Improvement

Interventions: Other: Audit and Feedback Bundle
Other: Bi-weekly audit and feedback emails

First Posted Date: 2015-11-01

Last Posted Date: 2017-05-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 200

Registration Number: NCT02593253

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Immunologic Response to Secukinumab in Plaque Psoriasis

Phase 4

Completed

Conditions: Psoriasis

Interventions: Drug: Secukinumab

First Posted Date: 2015-10-30

Last Posted Date: 2020-09-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 15

Registration Number: NCT02592018

Locations: 🇺🇸
UCSF Psoriasis and Skin Treatment Center, San Francisco, California, United States

Transcorporal Versus Standard Artificial Urinary Sphincter Placement

Not Applicable

Terminated

Conditions: Urinary Stress Incontinence

Interventions: Procedure: Artificial Urinary Sphincter Placement

First Posted Date: 2015-10-29

Last Posted Date: 2018-05-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 3

Registration Number: NCT02591381

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma

Phase 2

Terminated

Conditions: ALK Fusion Protein Expression
NRAS wt Allele
NTRK1 Fusion Positive
NTRK2 Fusion Positive
NTRK3 Fusion Positive
RET Fusion Positive
ROS1 Fusion Positive
Stage IV Cutaneous Melanoma
Stage IIIA Cutaneous Melanoma
Stage IIIB Cutaneous Melanoma

Interventions: Drug: Capmatinib
Drug: Ceritinib
Drug: Entrectinib
Other: Laboratory Biomarker Analysis
Drug: Regorafenib

First Posted Date: 2015-10-27

Last Posted Date: 2020-01-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1

Registration Number: NCT02587650

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder Functional Outcomes

Not Applicable

Completed

Conditions: Rotator Cuff Tear Arthropathy

Interventions: Drug: Placebo
Drug: Ibuprofen

First Posted Date: 2015-10-27

Last Posted Date: 2024-12-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 110

Registration Number: NCT02588027

Locations: 🇺🇸
UCSF Orthopaedic Institute, San Francisco, California, United States

Changes in Sugar-sweetened Beverage Intake and Metabolic Health: Improving Metabolic Profile Very Effortlessly

Not Applicable

Completed

Conditions: Metabolic Health

Interventions: Behavioral: Brief intervention

First Posted Date: 2015-10-23

Last Posted Date: 2021-01-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 214

Registration Number: NCT02585336

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Adult Oxytocin Study

Early Phase 1

Completed

Conditions: Schizophrenia
Oxytocin
Social Cognition

Interventions: Drug: Saline Nasal Spray
Drug: Oxytocin

First Posted Date: 2015-10-16

Last Posted Date: 2019-05-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 120

Registration Number: NCT02577575

Locations: 🇺🇸
San Francisco Veterans Affairs Medical Center, San Francisco, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

Assessment of 2012 Bioequivalence Standards for Warfarin

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: warfarin

First Posted Date: 2015-10-14

Last Posted Date: 2019-08-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT02574754

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy